PHOENIX — The Blood and Marrow Transplant (BMT) Program at Mayo Clinic in Arizona and Phoenix Children's Hospital ranked second among all U.S. BMT programs for one-year survival rates for patients for the period between 2008 and 2010. Data was reported last month by the Center for International Blood and Marrow Transplant Research (CIBMTR), a combined research program of the National Marrow Donor Program and the Medical College of Wisconsin.
The ranking is based on data from 79 adult or combined adult/pediatric programs that reported survival data for at least 50 allogeneic (stem cells from a donor) patients to the CIBMTR over the 2008–2010 reporting period.
The 75 percent one-year survival rate achieved by the collaborative Mayo Clinic and Phoenix Children's Hospital program compares to a median of 62 percent for all 79 ranked programs, and is at the very high end of the expected range of 61 to 75 percent for programs transplanting similar risk patients.
"The report from the CIBMTR is a reflection of the hard work, compassion and dedication to patient care shown by all of the BMT staff at Mayo Clinic in Arizona and Phoenix Children's Hospital and is a testament to the courage and tenacity of the patients who have placed their trust in us as their transplant team," says the program's director, Mayo Clinic's
Pierre Noel, M.D.
As mandated by federal law, all BMT programs in the U.S. are required to submit outcome data to the CIBMTR, which publishes the data annually for viewing by patients, families and the general public. The data is adjusted for risk factors that influence outcomes, such as type of disease, patient age and degree of match.
Phoenix Children's Hospital is Arizona's only licensed children's hospital, providing world-class inpatient, outpatient, trauma, emergency and urgent care to children and families in Arizona and throughout the Southwest. As one of the largest children's hospitals in the country with 465 licensed beds, Phoenix Children's provides care across more than 65 pediatric specialties.